Antimicrobial susceptibility testing: Special needs for fastidious organisms and difficult-to-detect resistance mechanisms

Clinical Infectious Diseases

Volumn 30, Issue 5, 2000, Pages 799-808

  Jorgensen, James H ^a   Ferraro, Mary Jane ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; VANCOMYCIN;

ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROBACTERIACEAE; ENTEROCOCCUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SCREENING; STREPTOCOCCUS PNEUMONIAE;

ANTIBIOTICS; BACTERIA; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; DRUG RESISTANCE, MICROBIAL; HUMAN; MICROBIAL SENSITIVITY TESTS;

STAPHYLOCOCCUS AUREUS;

EID: 0033802837     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313788     Document Type: Article

References (49)

1. Antimicrobial susceptibility testing: General principles and contemporary practices
2. Antimicrobial-drug resistance
3. Genetic methods for detecting antibacterial and antiviral resistance genes
4. Special phenotypic methods for detecting antibacterial resistance
5. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)
6. 1998 Guidelines for treatment of sexually transmitted diseases
7. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers for Disease Control and Prevention's pneumococcal sentinel surveillance system
8. Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: Results of a 1992-1993 western Europe and USA collaborative surveillance study
9. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States
10. Evaluation of the Dade MicroScan M1CroSTREP antimicrobial susceptibility testing panel with selected Streptococcus pneumoniae challenge strains and recent clinical isolates
11. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by the use of E test
12. Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae
13. Antimicrobial susceptibility testing of Helicobacter pylori: Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole
14. Susceptibility testing of anaerobic bacteria
15. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994
16. Evaluation of the epsilometer (E test) for susceptibility testing of anaerobic bacteria
17. Mechanisms of resistance to antimicrobial agents
18. Two percent sodium chloride is required for susceptibility testing of staphylococci with oxacillin when using agar-based dilution methods
19. Revised interpretation of oxacillin MICs for Staphylococcus epidermidis based on mecA detection
20. Staphylococcus aureus and coagulase-negative staphylococci from bloodstream infections: Frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program
21. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus
22. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
23. Emergence of vancomycin resistance in Staphylococcus aureus
24. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection
25. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides
26. Emergence of vancomycin resistance in coagulase-negative staphylococci
27. Peritonitis due to vancomycin-resistant Staphylococcus epidermidis
28. Interim guidelines for prevention and control of staphylococcal infections associated with reduced susceptibility to vancomycin
29. Recommendations for preventing the spread of vancomycin resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)
30. Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci
31. Detection of vancomycin resistance in Enterococcus species
32. Development of a standardized screening method for detection of vancomycin-resistant enterococci
33. Resistance to glycopeptides in enterococci
34. Identification of gram-positive coccal and coccobacillary vancomycin-resistant bacteria
35. Reliability of the E test for detection of ampicillin, vancomycin, and high-level aminoglycoside resistance in Enterococcus species
36. Use of tests for acidification of methyl-a-D-glucopyranoside and susceptibility to efrotomycin for differentiation of strains of Enterococcus and some related genera
37. Inducible ampC β-lactamase producing gram-negative bacilli from blood stream infections: Frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE)
38. β-Lactam resistance in gram-negative bacteria: Global trends and clinical impact
39. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy
40. Extended-spectrum β-lactamases and other enzymes providing resistance to oxyimino-β-lactams
41. Nosocomial outbreak of klebsiella infection resistant to late-generation cephalosporins
42. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center
43. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases
44. Multiplexed biological assays with biological chips